|
(P537) |
Treatment strategies and clinical outcomes in small vessel coronary artery disease: a meta-analytic approach |
| |
|
T. Stephan, F. Bozic, B. Mayer, D. Felbel, S. d'Almeida, M. Rattka, W. Rottbauer, S. Markovic (Ulm) |
|
(P538) |
The Bioengineered Combo Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent in Patients with chronic total occlusion- evaluated by clinical outcome and Optical Coherence Tomography |
| |
|
R. Blessing, M. Ahoopai, M. Geyer, M. Brandt, A. M. Zeiher, T. Münzel, P. Wenzel, T. Gori, Z. Dimitriadis (Mainz, Frankfurt am Main) |
|
(P539) |
FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 2 Year Outcomes |
| |
|
M. Lutz, S. Pyxaras, S. Kische, N. Frey, für die Studiengruppe: FANTOM II (Kiel, Landshut, Berlin, Heidelberg) |
|
(P540) |
30-day outcomes of transradial versus transfemoral access in patients treated with percutaneous coronary intervention – results from the German Austrian ABSORB registry (GABI-R) |
| |
|
B. Wein, M. Zaczkiewicz, M. Graf, O. Zimmermann, J. Kastner, J. Wöhrle, T. Riemer, C. W. Hamm, S. Achenbach, G. Richardt, T. Gori, H. Nef, J. Mehilli, J. Torzewski, für die Studiengruppe: GABI-R (Kempten, Immenstadt, Friedrichshafen, Ludwigshafen am Rhein, Gießen, Erlangen, Bad Segeberg, Mainz, Landshut; Wien, AT) |
|
(P541) |
First real world safety and performance analysis of the routine clinical use of the Tyrocore-based sirolimus-eluting bioresorbable coronary scaffold |
| |
|
M. Lutz, M. Krämer, G. Leibundgut, C. Kuhn, M. Rosenberg, N. Frey (Kiel, Landau in der Pfalz, Aschaffenburg, Heidelberg; Liestal, CH) |
|
(P542) |
Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 30 Day Clinical Outcomes in First 75 Patients |
| |
|
M. Lutz, S. Otto, K. Pujdak, G. Leibundgut, N. Frey, für die Studiengruppe: Fantom-PMC (Kiel, Jena, Herford, Heidelberg; Liestal, CH) |
|
(P543) |
Mechanical unloading by Impella CP in postinfarction posterior ventricular septal defect, Briding to repair: first case series |
| |
|
T. Ghazy, A. Youssef, K. Ibrahim, M. Christoph, M. Vondran, A. Abugameh, A. Rastan (Marburg, Chemnitz, Rotenburg an der Fulda) |
|
(P544) |
Usefulness of LVEDP measurement in patients with acute myocardial infarction complicated by cardiogenic shock treated with Impella |
| |
|
F. Al-Rashid, A. A. Alabdo, L. Johannsen, A.-A. Mahabadi, M. Totzeck, R. A. Janosi, T. Rassaf (Essen) |
|
(P545) |
Relationship between hospital volume and likelihood of stent implantation among patients undergoing catheterization of the left heart |
| |
|
V. Oettinger, M. Zehender, C. von zur Mühlen, C. Bode, K. Kaier, P. Stachon (Freiburg im Breisgau) |
|
(P546) |
10-Year clinical outcomes of biodegradable versus durable polymer new-generation DES in patients with coronary artery disease with and without diabetes mellitus |
| |
|
T. Koch, T. Lenz, M. Joner, E. Xhepa, J. Wiebe, J. Coughlan, A. Aytekin, T. Ibrahim, M. Fusaro, S. Cassese, K.-L. Laugwitz, H. Schunkert, A. Kastrati, S. Kufner, für die Studiengruppe: ISAResearch Center (München) |